Search

everythinglearnresearchcommunity

for

Search:↓

A 21-year-old male shared his nearly 4-year experience with hair loss treatments, including finasteride, minoxidil, and other products, with initial success followed by shedding. He now continues with finasteride and oral minoxidil, noting changes in hair texture and slight hairline recession.

A user shared their experience with male pattern baldness and accepting baldness after shaving their head at age 29. Some responses suggest treatments like minoxidil and finasteride, while others discuss acceptance and personal experiences with hair loss.

A user took 1mg finasteride and 2.5mg minoxidil daily for three years, which significantly improved their hair loss and mental health. They recommend starting treatment early and shared progress pictures showing noticeable improvement, especially in the last year.

A user is experiencing renewed hair loss despite using minoxidil and finasteride for two years and is considering options like dutasteride, increasing finasteride dosage, or starting microneedling. Respondents suggest waiting another month before making changes, consulting a dermatologist, and potentially adjusting the treatment regimen.

The user is treating hair loss with a regimen including Dutasteride, oral and topical Minoxidil, microneedling, and various supplements for overall health. They are considering adding tretinoin, stemoxydine/RU, DIM, Boron, and Fadogia Agretis to their routine.

A user did not respond to finasteride, dutasteride, and oral minoxidil for hair loss after four years of treatment and is considering scalp micropigmentation (SMP). Other users suggest the hair loss pattern may indicate alopecia areata and recommend seeing a dermatologist.

The half-life of Dutasteride is commonly stated as around 5 weeks, but some sources suggest it is 170 hours for men aged 20–49, with further information indicating it varies from 3 days to 5 weeks depending on the dose. The user is seeking clarity on these conflicting figures.

The conversation discusses the safety and cost of 2.5mg Dutasteride, and the potential for increased DHT reduction by combining Dutasteride with topical Finasteride. The original poster is currently using 0.5mg Dutasteride, 1.25mg oral Minoxidil, and a topical treatment, and is considering increasing the dosage to maximize results while avoiding less known treatments like RU58841.

The user is using minoxidil and recently started fluridil for mild hair loss and is questioning if this treatment is sufficient without finasteride. They have finasteride available but prefer not to use it.

Some users of RU-58841 report cardiovascular symptoms like heart palpitations and chest tightness, which may be linked to its metabolites causing lung disease. The safety of RU-58841 is uncertain due to lack of long-term data and concerns about product purity, especially from gray market sources.